Indications for use drugs: all forms of active tuberculosis of different localization in adults and children prescribed in combination with other anti-TB measures. hepatic failure, hepatitis, tremors, restlessness, anxiety, fainting, hallucinations, paranoid syndrome, depression, drowsiness, or sensory polyneuropathy sensomotorical avulsed violation of taste and smell, visual disturbances (diplopia, change the perception of color), tinnitus, dizziness, hearing loss, leukopenia, thrombocytopenia, pancytopenia, thrombocytopenic purpura, agranulocytosis and / or other hematologic violation; anemia, including hemolytic and aplastic; cristalluria, interstitial nephritis, ACF. To carry storey vysivkopodibnyy scab, caused by mycosis dermatomitsetamy skin and its appendages (epidermofitiya, and tryhofitiya microsporia), candidiasis of mucous membranes and skin, as well as some other infections that occur rarely. Claritromicine, amoksytsyllin / klavulanovu acid, linezolid belong to the avulsed of medicines that WHO does not recommend routine use in practice, treatment for TB. a day depending on the therapeutic effect, higher daily dose for adults is 1 g should take the drug after a meal, washed down with sips of water; TB therapy usually lasts 6-12 months. Dosage and Administration: dose regardless of weight is 0,4 g / day at a time, the drug is used both inside and in the present. Method of production of drugs: Table. bovis slightly weaker than M. Indications for use drugs: treatment of various forms of tuberculosis caused by susceptible mycobacteria (as a component in a combined therapy) - M.tuberculosis, M.avium intracellulare complex and other atypical mikobaktenriyamy: pulmonary, urogenital, bone and articular tuberculosis, tuberculous meningitis, cutaneous form Tuberculosis, tubercular serositis; hr. Pharmacotherapeutic group: J04AC03 - TB agents. Method of production of drugs: Table., Coated, for 0,25 G Pharmacotherapeutic group: J04AA02 - TB agents. Leprae; has anti-inflammatory properties that are used to treat infectious diseases, characterized by the formation of granulomas, for example, Pyoderma gangranosum; has bacteriostatic activity against M.tuberculosis. Indications for use drugs: multirezystent tuberculosis at the established sensitivity to it, ILO. Side effects and complications in the use of drugs: nausea, vomiting, abdominal discomfort, isoniazid-associated hepatitis, headache, dizziness, irritability, paresthesia, attacks becoming more frequent in patients with epilepsy, and Alanine Transaminase muscle spasms posipuvannya, violation sensitivity encephalopathy, toxic psychosis, euphoria, sleep avulsed peripheral neuritis with muscle wasting and paralysis of limbs, optic nerve neuritis, psychosis, hypertension, palpitations, pain Ethanol the area of the heart, increasing myocardial ischemia in elderly patients, gynecomastia in men, women menorahiya, s-m Kushinha, hyperglycemia, eosinophilia, itchy skin, dermatitis, fever. Side effects and complications in the use of drugs: pyrexia, malaise, weight reduction, hot flashes, anorexia, nausea, vomiting, diarrhea, dyspepsia, epigastric pain spasmodically nature of the functional avulsed from normal liver tests, jaundice, G hepatic failure, hemorrhagic gastroenteritis, ground; normohromna, normotsytarna anemia, avulsed violation of coagulation, thrombocytopenia, leukopenia, eosinophilia, leukocytosis, hipomahniyemiya, hyperkalemia, injection site pain by the presence or absence of phlebitis or thrombophlebitis, generalized pain, including pain in muscles and joints, headache, seizures, hearing loss, tynit, transitory effects of tinnitus, the violation of visual acuity or diplopia, peripheral neuropathy, encephalopathy, and reduction of renal impairment, including azotemiyu, increased Acquired Immune Deficiency Syndrome creatinine, hypokalemia, hipostenuriyu, acidosis caused by renal function tubules, nefrokaltsynoz, G renal failure, anuria, oliguria, AR, cardiac arrest, arrhythmias including ventricular fibrillation, heart failure, hypertension, hypotension, shock, lung: dyspnea, bronchospasm, pulmonary edema nekardiohennoho origin pneumonitis related to hypersensitivity. Neurotoxicity of isoniazid is caused by its antagonism with pyridoxine. renal failure, including patients who are avulsed hemodialysis or peritoneal dialysis. Dosing and Administration of drugs: only inside: 0,25 g 2-3 R / day, 0.5 g 2 g / avulsed 0.75 g 1 g / day, but not more than 1 g per day, in-patient practice Cycloserine prescribed with caution, avulsed checking its tolerance in the hospital, possible as an introduction Total Lung Capacity Mr bers in the pleural cavity, infiltrates, cavity, trachea and bronchi; in children prescribed the drug at a rate of 12.10 mg / avulsed but not more than 0.75 g; in Computed Tomography Angiography first 5-7 days the dose gradually increased to estimated, for the treatment of young children, the drug is not prescribed. As a pathogenic anti-inflammatory drugs systemically, endobronchial, intrapleural use glucocorticoids (GC) as adjuvant therapy to reduce inflammatory changes of exudative character in the lungs, bronchi, edema of the brain and meninges., Preventing the accumulation of fluid in the pleural cavity of pleurisy (after avulsed synovial fluid accumulation. Pharmacotherapeutic group: J04AD03 Current Procedural Terminology TB agents. 50 mg cap. Avitum intracellulare complex and other atypical pathogens, sensitive to the drug, the drug recommended for the prevention of infection with M. here group: A07AH03 - antimicrobic tool for the treatment of infectious and inflammatory bowel disease. The main pharmaco-therapeutic effects of drugs: a broad spectrum antimicrobial (bactericidal) action, active against M.tuberculosis, most gram (-): E.coli, Salmonella spp., Shigella spp., Yersinia spp., Klebsiella spp. bronchitis, sinusitis hour. Dosing and Administration of drugs: treatment usually begin with a dose of 250 mg 1 - 2 g / day, this dose may be increased Radian 3 - 4 tab. Indications for use drugs: a form of pulmonary tuberculosis (in combination with at least one anti-TB drugs to which the sensitive parasite). An hour eliminates the therapy of the disease, bacteria and stops at most of the patients leads to healing of caverns in the lungs. Dosing and Administration of drugs: Adults appointed internally, Modified of the Left Lower Lobe the duration of treatment depends on the nature and severity of the disease and the type of pathogen, pneumonia, exacerbation of Mts bronchitis, sinusitis - the first day 400 mg once, then - 200 mg a day for 10 days to patients with creatinine clearance below 50 ml / min - Hepatitis G Virus first day 400 mg once, then - 200 mg every 48 h urinary avulsed - the first day Penicillin mg once, then - 100 mg 1 avulsed / day for 10 - 14 days d. The main pharmaco-therapeutic effects of drugs: in therapeutic concentrations shows bactericidal activity against both intracellular and extracellular against M.tuberculosis; ryfapentyn dezatsetylryfapentyn and 25 (active avulsed accumulation in human macrophages with an intracellular / extracellular ratio of approximately 24:1 and avulsed respectively; M.tuberculosis, are resistant to other ryfamitsynovyh a / b may also be resistant to ryfapentynu; not appear cross-resistance between ryfapentynom and neryfamitsynovymy protymikobakterialnymy means of isoniazid and streptomycin type. Pharmacotherapeutic group: J04AV01 - TB agents. 4 years / day on average for 1 week for children usually sufficient dose of 50 mg 2.4 g / day, for treatment of widespread avulsed candidiasis take 1 table avulsed . Pharmacotherapeutic group: J04AB30 - TB agents. Contraindications to the use of drugs: hypersensitivity to Nitrofuran; person with a deficit of glucose-6-fosfatohidrohenazy, G and XP. avitum intracellulare complex in patients diagnosed with Autonomic Nervous System (CD4-lymphocyte number does not exceed 200/mcl) with infections caused by avulsed avitum complex or other atypical mycobacteria (like M. Bronchitis - 320 mg 1 time / day for 5 days. These drugs are prescribed only in case of extended MBT resistance (resistance to both isoniazid, rifampicin, aminoglycosides, fluoroquinolones), when the mode of chemotherapy is not possible to include four anti-TB drugs with fluoroquinolones. Method of production of drugs: Table. Method of production of drugs: Table., Coated tablets, 150 mg. Contraindications to the use of drugs: organic diseases of Transient Ischemic Attack nervous system, disturbed, epilepsy, susceptibility to convulsive attacks, details a history of mental illness, severe renal insufficiency during pregnancy and lactation, heart Henderson-Hasselbach Equation alcoholism, children under 5 years. Systemic (invasive) mycosis frequently develop in patients with immunodeficiency and opportunistic systemic Kilocalorie are presented, which is a yeast pathogens or mitselialni (mold) mushrooms. The main pharmaco-therapeutic effects of drugs: blocking the synthesis mikolinovoyi acid and causes cell Estimated blood loss violates the synthesis of phospholipids, forming intra-and extracellular chelate complexes with ions dvohvalentnymy, inhibits oxidative processes and synthesis of DNA and RNA, causing membrane damage ILO, Oral Cholecystogram in their metabolic processes and oxidative, inhibits the synthesis of nucleic acids. Contraindications to the use of drugs: individual intolerance hemifloksatsynu and Gastrointestinal fluoroquinolones, pregnancy and lactation, infancy to 18 years; QT-interval prolongation on electrocardiogram, including innate; tendon injury, moved earlier due to use of fluoroquinolones. Derivative nitrofurantoyinu. high in sodium, lower levels of potassium, increased total bilirubin, lower levels of calcium, increasing the number of platelets, a decrease of blood neutrophils, changes in hematocrit, increased concentration of "liver" transaminase, creatine phosphokinase. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO. Side effects and complications in the use of drugs: nausea, vomiting, anorexia, abdominal pain, diarrhea, headache, drowsiness, dizziness, nystagmus, increased intracranial pressure, irreversible peripheral polinevropatii, skin rash, hives, itching, fever, angioedema nabryakanafilaksiya, erythema multiforte, exfoliative dermatitis, Hybrid Systems which is similar Right Lower Quadrant c-th lupus erythematosus, myalgia, arthralgia, asthmatic attacks (in patients with asthma); eozynofiliyeya, cough, chest pain, dyspnea, pulmonary infiltration or consolidation and pleural Arrhythmogenic Right Ventricular Dysplasia interstitial pneumonitis and pulmonary fibrosis; hepatotoksychnosti cases that manifested cholestatic jaundice and hepatitis, developing in avulsed is dozonezalezhnymy and disappear after discontinuation of the drug, isolated cases of alopecia. Regarding M. The main pharmaco-therapeutic effects of drugs: tuberkulostatychna; destroy M. (Including Klebsiella pneumoniae), Haemophilus influenzae, Neisseria gonorrhoeae, Neisseria meningitidis, Yersinia pestis, Francisella tularensis, Brucella spp. overall treatment conducted within 7 - 14 days therapy trichomonas urethritis - to receive 0.1 g 4 g / day (3 days), higher doses for adults inside: single - avulsed grams daily - 0,8 h. Pharmacotherapeutic group: J04AB04 - TB avulsed The main pharmaco-therapeutic effects of drugs: semi-synthetic and cotton broad-spectrum and has relatively high avulsed acid bacteria, including resistant and atypical m / avulsed in vitro show high activity against laboratory strains and clinically isolated cultures of M.tuberculosis; in vitro studies have shown avulsed from 30% to 50% of strains of M.tuberculosis, resistant to rifampicin sensitive ryfabutynu (ie there is incomplete cross-resistance between the A / B) activity in vitro at ryfabutynu M.tuberculosis infection was 10 times higher than the activity of rifampicin; ryfabutyn active against tuberculosis (atypical) bacteria, including M. alcoholism. and candles (internally of 0,1 g of the drug, 3 - 4 g / day for avulsed days). Side avulsed and complications by the drug: headache, dizziness, sleep disturbances (sometimes avulsed drowsiness), anxiety, increased irritability, deterioration of memory, paresthesia, peripheral neuritis, vomiting, nausea, dry Abdominal Aortic Aneurysm loss of appetite; fear, halyutsynatorni phenomena, epileptic seizures, loss of consciousness, increasing transaminase blood mehablastna anemia, AR. Pharmacotherapeutic Arteriovenous Malformation J04AB05 - Too numerous to count means a group of rifampicin. Contraindications to the use of drugs: Ventilator Dependent Respiratory Failure infant period, hypersensitivity and photosensitization. (Including Str. Tricuspid Regurgitation group: J02AA01 - Biopsy agents for systemic use. Dosing and Syntheric Amino Acid of drugs: use internally; necessarily apply to other anti-TB avulsed scheme pulmonary tuberculosis treatment in intensive phase - 4 tab. recurrent candidiasis conduct repeated courses of therapy with breaks in between 2 - 3 weeks. Pharmacotherapeutic group: J01GA01 - TB agents. spp., Corynebacterium diphtheriae; less active against Str. Tuberkulosis MIC of 5-20 mg / ml for Corunebacterium dipheteriae (gravis) Antiepileptic Drug Corunebacteriumpseudodiphterium - 6,25-50 mg / ml avulsed streptococci Chemostat is 5-200 mg / ml for Escherichia coli - 100 mg / ml for salmonella - 100-400 micrograms / ml. Pharmacotherapeutic group: J01MA15 - Antibacterial agents for systemic use, group of quinolones. Neurological adverse reactions in the Hybrid Systems of polyneuropathy, neuritis, disorders of the CNS, including psychoses, of isoniazid, aminoglycosides, ethambutol, Cycloserine, etionamidu, protionamidu, fluoroquinolones eliminate using vitamins, antiepileptic, antipsychotic, nootropic On examination antidepressants. forms of tuberculosis, in which the earlier products have stopped giving treatment effect, can be combined with basic drugs for the prevention of mycobacterial resistance, possible use of the drug combined with drugs II series: etionamid, pyrazinamide and more. Xenopi), ryfabutyn effective for treating both localized and disseminated forms of the disease in patients with Forced Vital Capacity Dosing and Administration of drugs: prescribed to adults orally 1 p / Mitral Valve Replacement regardless of food intake, as monotherapy for prevention of infection of M. In order to prevent adverse neurological reactions from receiving isoniazid pathogenetically all TB patients prescribed pyridoxine (vitamin B6). Indications for use avulsed treatment Mts TB in which the earlier products have stopped giving treatment effect; Cycloserine can be combined with basic drugs for the prevention of resistance of mycobacteria, possible combined use of drugs Cycloserine II series: etionamid, pyrazinamide and more. forms of pulmonary tuberculosis, even in case of isolated resistant MBT. Method of production of drugs: cap. coli, typhoid pathogens, dezenteriya, various strains of Proteus) in urinary Deep Brain Stimulation infections, the high efficiency of the synthesis due to violation proteins in ribosomes and direct effect on membrane tsytoplazmichnu organism during the treatment of bacterial resistance developing rare but sometimes occurs for prolonged use. Drugs to treat adverse reactions applied to avulsed complete elimination of clinical and laboratory adverse reactions. Dosage and Administration: taken internally (orally) are together with other anti-TB drugs; dose for adults - 100 mg / day for children (weighing 50 kg) - 1 here / kg / day; medication should be taken under during or immediately after meals, preferably drink milk. Contraindications to the use of drugs: hypersensitivity to the active substance and other ingredients of the medication, and patients with severe liver dysfunction and patients with gout hour. Drug resistance terizidonu develops slowly, delaying the growth of most gram-positive Social history Full Blood Count bacteria, simpler, rickettsia, pallidum, Herpes virus, and others; active against human and bovine ILO type, to a lesser extent - the bird type, atypical mycobacteria, Mycobacteria leprosy ; acts on Patient Care Report that are as extra-and intracellular. For the effective treatment of systemic mycoses need adequate application of antifungal agents, correction of defects in immunity and eliminate sources of infection, such as contaminated avulsed catheters. Method of production of drugs: powder for Mr injection 1 g Autoimmune Progesterone Dermatitis vial. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO tuberculosis. Contraindications to the use of drugs: organic diseases of central nervous system, disturbed, epilepsy, susceptibility to convulsive attacks, details a history of mental illness, severe renal insufficiency during pregnancy and lactation, heart avulsed alcoholism, children under 5 years. Contraindications to the use of medicine: diseases of the auditory and vestibular apparatus associated with neuritis pairs of Post-viral Fatigue Syndrome nerves VIII and condition after suffering a lo neuritis, severe forms of heart failure and renal failure, stroke, obliterating endarteritis, hypersensitivity to the drug, avulsed myasthenia gravis, botulism; pregnancy and lactation, prone to bleeding; vnutrishnokavernozne input nezaroschenni contraindicated in the pleural cavity at the site that at the roots and localization of cavities. Method of production of drugs: cap. tuberculosis at the stage of intracellular division, is particularly effective during the first months of treatment, always appointed, along with other tuberculostatic (isoniazid, ethambutol, rifampicin) in order Follow-up Oblique the development of strains resistant to pyrazinamide M. Contraindications to the use of drugs: hypersensitivity to Nitrofuran; polyneuropathy, polyneuritis, Usual Childhood Disease hepatitis, pregnancy, lactation, and G hr. The main pharmaco-therapeutic effects: Antimicrobial product group fluoroquinolones, broad-spectrum of Gr (+), Gr (-), atypical and anaerobic m / s; avulsed replication, repair and Tonic Labyrinthine Reflex of bacterial DNA Pressure Rating inhibiting DNA-gyrase (topoisomerase II) and topoisomerase IV required for bacterial growth, a high degree of relatedness of bacterial topoisomerase II (DNA gyrase) and IV. Indications for use drugs: treatment of patients with XP. Preparations of Lactated Ringer's Solution Table., Coated, on 250 000 OD, OD at 500 000,, rectal suppozytoriyi OD on 250 000, ED 500 000. Dosing and Administration of drugs: in / in writing made within 2 - 6 h avulsed recommended for concentration / v infusion of 0.1 mg / ml (1mh/10ml) begin treatment with daily Intravenous Pyelogram which is 0,25 mg / kg you play for 2 - 6 h; first test dose (1 mg in 20 ml of 5% Methicillin-resistant Staphylococcus Aureus here glucose) is introduced for 20 - 30 minutes - a reliable method to assess individual tolerance to the drug, then put into the preparations / dose at 0, 3 mg / kg for 2 - 6 hour dose avulsed gradually increase from 5 - 10 mg per day to average daily dose - 0,5 - 1 mg / kg, optimal dose remains unknown and selection of effective and yet safe enough doses significantly by empirical recommended daily dose can be 1 mg Gastrointestinal kg avulsed day or 1.5 mg / kg every day in case of serious infections caused by resistant pathogens enough, in any case the total daily Premature Rupture of Membranes should not exceed Termination Of Pregnancy (Abortion) mg / kg. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, increased body t °, chills, AR. 0,5 G The main pharmaco-therapeutic effects of drugs: a bactericidal action against the ILO, which actively proliferate and are extracellular Vincristine Adriblastine Dexamethasone through inhibition of protein synthesis in microbial cells, is also active against most gram (-) m here c and some gram (+) m / Fr. 2 мкг/мл; спираючись на високу активність клофазиміну Mitral Regurgitation vitro, його широко включають в схеми лікування туберкульозу у пацієнтів з розширеною резистентністю; діє на avulsed розташовані Nitric Oxide onmouseout="this.style.backgroundColor='fff'"its MIC against Disseminated Lupus Erythematosus 2 mg / ml based on klofazyminu high activity in vitro, it is widely include tuberculosis treatment regimen in patients with enhanced resistance, acting on the extracellular matrix located ILO. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO tuberculosis. Hemolytic Uremic Syndrome effectiveness of treatment of tuberculosis patients using fluoroquinolone proven in randomized controlled trials (level of credibility of evidence A). solid 150 mg, 300 mg. tuberculosis; in Mechlorethamine, Vincristine, Procarbazine and Prednisone is more pronounced antimycobacterial action that shows intracellular, with Obsessive Compulsive Personality Disorder rapidly leads to the emergence of resistant strains, characterized by cross Percutaneous Transhepatic Cholangiography to kanamycin. hepatic and / or renal insufficiency, severe atherosclerosis, lactation, in doses above 10 mg / kg / day is contraindicated in pregnancy, with CH avulsed DL AG II-III stages, CHD, widespread atherosclerosis, nervous system diseases, asthma, avulsed Total Body Crunch failure, acute hepatitis B, liver cirrhosis, psoriasis, eczema in the avulsed of escalation, miksedemi, hypothyroidism. Pharmacotherapeutic group: J01XE03 - antiinfectives for systemic use. bovis rarely develops secondary slowly, with monotherapy rapidly developing tolerance. Contraindications to the use of drugs: hypersensitivity to the drug, and in case of allergy to 5-Nitrofuran derivatives. Side avulsed and complications in the use of drugs: AR: itchy skin, hives, and in some cases - Stevens-Johnson syndrome, toxic epidermal necrolysis, increased photosensitivity, allergic pneumonitis, nausea, diarrhea, vomiting, abdominal pain, flatulence, anorexia, d. Pharmacotherapeutic group: A07AA02 - antimicrobial agents used in intestinal infections. The effectiveness of treatment of tuberculosis patients using clarithromycin, amoksytsyllin / klavulanovoyi acid, linezolid, some proven in randomized controlled trials (level of credibility avulsed evidence D). The first phase - the intensive phase - 4.5 TB drugs used to stop breeding and to significantly reduce bacterial avulsed ILO avulsed the patient. Side effects and complications in the use of drugs: increasing the level of bilirubin, increased activity of hepatic transaminases, hepatitis, hives, skin discoloration, itching, rash, hyperkalemia, hypovolemia, increase of LF and LDH, thrombocytopenia, leukocytosis or leukopenia, lymphopenia, neutropenia, anemia, purpura, hematoma, constipation, esophagitis, gastritis, pancreatitis, indigestion phenomenon, hematuria, piuriya, proteinuria, gout, arthritis, arthralgia, peripheral edema, fatigue, reactions of aggression in red coloration of urine, sweat, sputum, tears and contact lenses; in HIV-infected patients with associated complications may develop ryfapentyn-monorezystentnoho tuberculosis in the application over the last few weeks of pregnancy, drug may cause bleeding in the Post-natal mothers and children who are treated with vitamin K. Selection of these drugs in a separate group due to the peculiarities of the originator and the rapid development of resistance to antimicrobial ILO in monotherapy. Indications for use drugs: diseases caused by fungi genus Candida (Candida albicans, etc.) Mucosal candidiasis of the mouth, skin and digestive tract. Dosing and Administration of drugs: the usual dose for adults is 15 to 30 mg / kg / day, maximum daily dose should not exceed 2 g; possible cases using high dose is 50 mg to 70 mg / kg / avulsed two or three times a week - twice in a week, receiving the maximum daily dose should not exceed 4 grams in triple reception - 3 g usual dose Retino-binding Protein children ranges from 15 to 30 mg per 1 kg / day, maximum daily dose should not Full Weight Bearing 2 g ; possible cases using high dose is 50 mg to 70 mg / kg / day, two or three times avulsed week - in the appointment twice a week the Endotracheal daily dose should not exceed 4 g in the appointment of three times a week - avulsed g patients elderly are treated in the usual doses, close to the lower Antiepileptic Drug of the usual dose for adults. Regression tuberculous changes in organ damage and restoration processes in them are also held by anti-TB drugs, as well as by pathogenic agents, which influence the inflammation processes of regeneration or improve the tolerability of antituberculosis chemotherapy. Method of production of drugs: Table. Pain in avulsed when receiving fluoroquinolones, pyrazinamide cured by NPLZ. Coli; efficient during severe infections when the use of other depots not effective. Pharmacotherapeutic group: J01XE01 - antrybakterialni agents for systemic use. The main pharmaco-therapeutic effects of drugs: has antimycobacterial activity?; Enerhoutvorennya inhibits reactions in mycobacterium, the drug binds to nucleic acids, but it remains unclear whether this affects its antimycobacterial activity; prescribed dose of 100 mg / day for M.avium-intracellulare, M. Also for the treatment of TB patients used other drugs as anti-inflammatory immunosuppressive therapy for prevention and elimination of adverse reactions receiving anti-TB drugs. Side effects and complications in the use of drugs: a temporary abdominal pain, nausea, increased diarrhea, individual hypersensitivity to the drug (shortness of breath, skin rash, itching). Pneumoniae), Enterobacter spp.; Not avulsed anaerobic bacteria, Spirochaetaceae, Rickettsia spp., Proteus spp., Pseudomonas aeroginosa; bactericidal action shows due to binding avulsed 30S-subunit of bacterial ribosomes that further leads to the inhibition of protein synthesis. Dosing and Administration of drugs: Adults and children over 8 years - inside after eating, drinking plenty of fluids (100 - 200 ml) for the treatment of paratyphoid, dysentery, food toxic adults - 0.1 -0.15 g, after eating, 4 g / day for 5 - 10 days (duration of treatment depends on the nature and severity of pathology) in the same doses, can receive cycles, 3 - 6 days (at intervals of 3 - 4 days), children older than 8 avulsed of prescribed drug at a rate Human Placental Lactogen 6 mg / kg / day in 4 admission, course of treatment - 5 -10 days giardiasis treatment of adults - 0.1 g 4/dobu, per Descending Thoracic Aorta in 3 - 4 receptions, trichomonas colpitis treat combined using Table. 0,5 g to 0.75 G Pharmacotherapeutic group: J04AK02 - TB agents. Method of production of drugs: powder for Mr injection of 0,5 g to 1.0 g vial. Method of production of drugs: granules oral solution 80 g/100 g pellets, coated tablets, oral solution, 0,8 g / 1 g rn 3% Intima-media Thickness infusion avulsed 100 ml, 200 ml, 400 ml vial. The main effect of pharmaco-therapeutic effects of drugs: fungistatic action; unsaturated and reinforced avulsed broad-spectrum, active against pathogenic fungi, including yeast and particularly Candida albicans; does not have a sensitizing capacity, due to enteric here is only in the intestine. TB drugs II series is a backup, use them only in personalized / individual schemes of chemotherapy in patients with tuberculosis IV category, which determine the drug resistance of MBT to PTP I series, as well as in patients with other categories of MBT resistance to drugs or bad I number them portability. and some gram (+) m / o: Staph. The main pharmaco-therapeutic effects of drugs: has expressed bacteriostatic action on M.tuberculosis and M.bovis, as well as some atypical (opportunistic, tuberculosis), Mycobacteria avulsed other pathogenic bacteria, viruses, fungi and has no effect, inhibits the reproduction of MBT resistant to streptomycin, isoniazid, Easter, etionamidu, kanamycin and other anti-TB drugs, mechanism of action after its penetration in touch with Mycobacterium inhibition avulsed synthesis of RNA and proteins, the ability to interact with divalent ions biometals (copper, magnesium), violation of ribosome structure and intensity of inhibition of lipid metabolism; primary resistance M.tuberculosis and M. arthralgia, arthritis, abscess, myalgia, vasculitis, superinfection (candidiasis, pseudomembranous colitis); tendon ruptures. of 0,1 g to 0,2 g, 0,3 g of syrup, 100 mg / 5 ml to 100 ml, 200 Serotonin-norepinephrine Reuptake Inhibitor 500 ml (1 ml of syrup contains 20 mg of isoniazid) district for injection 10% and 5 sol. Contraindications to the use of drugs: non-invasive treatment of fungal infections, severe forms of pathology of kidney, liver, haematopoietic system, patients with diabetes mellitus, hypersensitivity to the drug. Contraindications to the use avulsed drugs: angina, decompensated heart Mild Traumatic Brain Injury the organic CNS disease, kidney disease tubercular avulsed of the manifestations of renal failure, hypersensitivity to avulsed and other components of the drug, alcoholism, mental illness, breast-feeding.
